Novel Therapeutic Strategies in Acute Lymphoblastic Leukemia Ajoy DiasSaad J. KenderianMark R. Litzow Acute Lymphocytic Leukemias (K Ballen, Section Editor) 21 April 2016 Pages: 253 - 264
Scientific Achievements May Not Reach Everyone: Understanding Disparities in Acute Leukemia Manali I. Patel Health Economics (N Khera, Section Editor) 21 May 2016 Pages: 265 - 270
Exploring Big Data in Hematological Malignancies: Challenges and Opportunities Gustavo F. WestinAjoy L. DiasRonald S. Go Health Economics (N Khera, Section Editor) 13 May 2016 Pages: 271 - 279
Unmet Needs for Psychosocial Care in Hematologic Malignancies and Hematopoietic Cell Transplant Anna BarataWilliam A. WoodHeather S. L. Jim Health Economics (N Khera, Section Editor) 25 April 2016 Pages: 280 - 287
Oral Chemotherapy in Patients with Hematological Malignancies—Care Process, Pharmacoeconomic and Policy Implications Jeffrey BetcherElizabeth DowNandita Khera Health Economics (N Khera, Section Editor) 16 April 2016 Pages: 288 - 294
Bending the Cost Curve in Childhood Cancer Heidi RussellM. Brooke Bernhardt Health Economics (N Khera, Section Editor) 19 May 2016 Pages: 295 - 302
Value Based Care and Patient-Centered Care: Divergent or Complementary? Eric K. TsengLisa K. Hicks Health Economics (N Khera, Section Editor) 04 June 2016 Pages: 303 - 310
T-Cell Receptor-Engineered Cells for the Treatment of Hematologic Malignancies Nasheed M. HossainAude G. ChapuisRoland B. Walter CART and Immunotherapy (M Ruella, Section Editor) 19 April 2016 Pages: 311 - 317
Planes, Trains, and Automobiles: Perspectives on CAR T Cells and Other Cellular Therapies for Hematologic Malignancies Saar Gill CART and Immunotherapy (M Ruella, Section Editor) 02 May 2016 Pages: 318 - 325
